<code id='54EF0269AD'></code><style id='54EF0269AD'></style>
    • <acronym id='54EF0269AD'></acronym>
      <center id='54EF0269AD'><center id='54EF0269AD'><tfoot id='54EF0269AD'></tfoot></center><abbr id='54EF0269AD'><dir id='54EF0269AD'><tfoot id='54EF0269AD'></tfoot><noframes id='54EF0269AD'>

    • <optgroup id='54EF0269AD'><strike id='54EF0269AD'><sup id='54EF0269AD'></sup></strike><code id='54EF0269AD'></code></optgroup>
        1. <b id='54EF0269AD'><label id='54EF0269AD'><select id='54EF0269AD'><dt id='54EF0269AD'><span id='54EF0269AD'></span></dt></select></label></b><u id='54EF0269AD'></u>
          <i id='54EF0269AD'><strike id='54EF0269AD'><tt id='54EF0269AD'><pre id='54EF0269AD'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:4
          Adam's take main illustration
          Molly Ferguson/STAT

          Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

          A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

          advertisement

          With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Military medical care influenced by rank and race, new study finds
          Military medical care influenced by rank and race, new study finds

          SpencerPlatt/GettyImagesHigherrankingmilitaryofficersreceivemoreresourcesandbettercarethanlowranking

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Military medical care influenced by rank and race, new study finds

          SpencerPlatt/GettyImagesHigherrankingmilitaryofficersreceivemoreresourcesandbettercarethanlowranking